News

AbbVie pays OSE Immunotherapeutics $48M upfront for early-stage antibody targeting chronic inflammation

AbbVie is making good on its plans to search for new mechanisms of action, this time with French biotech OSE Immunotherapeutics for a monoclonal antibody targeting inflammation. AbbVie will pay $48 million upfront to OSE […]

Advertisement — Advertise with Biotech Networks
Advertisement — Advertise with Biotech Networks
News

Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $VCYT–Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines. Click here to view original post Click Here to Publish/Feature Your Company or […]

Advertisement — Advertise with Biotech Networks